HYPERLIPIDEMIA IN THE NEPHROTIC SYNDROME

被引：36

作者：

KEANE, WF

KASISKE, BL

机构：

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1990年 / 323卷 / 09期

关键词：

D O I：

10.1056/NEJM199008303230910

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：603 / 604

页数：2

共 10 条

[1] IMPAIRED RENAL MEVALONATE METABOLISM IN NEPHROTIC SYNDROME - A STIMULUS FOR INCREASED HEPATIC CHOLESTEROGENESIS INDEPENDENT OF GFR AND HYPOALBUMINEMIA [J].

GOLPER, TA ;

SWARTZ, SH .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1982, 31 (05) :471-476

[2] MANAGEMENT OF HYPERLIPIDEMIA OF KIDNEY-DISEASE [J].

GRUNDY, SM .

KIDNEY INTERNATIONAL, 1990, 37 (03) :847-853

[3] ABNORMALITIES OF LIPOPROTEIN METABOLISM IN PATIENTS WITH THE NEPHROTIC SYNDROME [J].

JOVEN, J ;

VILLABONA, C ;

VILELLA, E ;

MASANA, L ;

ALBERTI, R ;

VALLES, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (09) :579-584

[4] THE EFFECTS OF LOVASTATIN IN HYPERLIPIDEMIC PATIENTS WITH THE NEPHROTIC SYNDROME [J].

KASISKE, BL ;

VELOSA, JA ;

HALSTENSON, CE ;

LABELLE, P ;

LANGENDORFER, A ;

KEANE, WF .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 15 (01) :8-15

[5] LIPOPROTEIN DISTRIBUTION AND COMPOSITION IN THE HUMAN NEPHROTIC SYNDROME [J].

MULS, E ;

ROSSENEU, M ;

DANEELS, R ;

SCHURGERS, M ;

BOELAERT, J .

ATHEROSCLEROSIS, 1985, 54 (02) :225-237

[6]

RABELINK AJ, 1988, LANCET, V2, P1335

[7]

SCHMITZ PG, 1989, SEMIN NEPHROL, V9, P354

[8] LOVASTATIN THERAPY IN NEPHROTIC HYPERLIPIDEMIA - EFFECTS ON LIPOPROTEIN METABOLISM [J].

VEGA, GL ;

GRUNDY, SM .

KIDNEY INTERNATIONAL, 1988, 33 (06) :1160-1168

[9] LOW-DENSITY LIPOPROTEIN METABOLISM IN THE NEPHROTIC SYNDROME [J].

WARWICK, GL ;

CASLAKE, MJ ;

BOULTONJONES, JM ;

DAGEN, M ;

PACKARD, CJ ;

SHEPHERD, J .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (02) :187-192

[10]

1988, ARCH INTERN MED, V148, P36

← 1 →